BRCA1 and neoplasm: In relation to cancer, continued investigation into how specific gene mutations alter BRCA1 cell cycle checkpoint functions through the modulation of its transport and/or activity could provide new insights, and the study of intracellular shuttling of BRCA1 and its misregulation by mutations might have additional implications for clinical applications of variability in tumor cell sensitivity to chemotherapy.